Signaling and Regulation Breast Cancer Cells Proliferation Is Regulated by Tyrosine Phosphatase SHP 1 through c-jun N-Terminal Kinase and Cooperative Induction of RFX-1 and AP-4 Transcription Factors

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Marrow-Derived Macrophages Lipopolysaccharide-Stimulated Bone B Pathway in κ Independent NF-− B Pathways and an SHP-1 κ NF-and β CCAAT / Enhancer-Binding Protein Dependent − ( SHP-1 ) 2-Containing Tyrosine Phosphatase-1 Homology Domain Src Two Distinct IL-6 Production Is Positively Regulated

  2011cited by this paper
• Toxicological disruption of signaling homeostasis: tyrosine phosphatases as targets.

  2010cited by this paper
• EXPRESSION OF PTEN AND SHP1, INVESTIGATED FROM TISSUE MICROARRAYS IN PEDIATRIC ACUTE LYMPHOBLASTIC, LEUKEMIA

  2009cited by this paper
• Coordinated regulation by Shp2 tyrosine phosphatase of signaling events controlling insulin biosynthesis in pancreatic β-cells

  2009influential reference
• Mitogen‐activated protein kinase (MAPK) pathway mediates the oestrogen‐like activities of ginsenoside Rg1 in human breast cancer (MCF‐7) cells

  2009cited by this paper
• Long-range enhancer differentially regulated by c-Jun and JunD controls peptidylarginine deiminase-3 gene in keratinocytes.

  2008cited by this paper
• Disruption of c-Jun reduces cellular migration and invasion through inhibition of c-Src and hyperactivation of ROCK II kinase.

  2008cited by this paper
• Evidence for a role of the Simian Virus 40 in human breast carcinomas

  2008cited by this paper
• IGF‐1 activates hEAG K+ channels through an Akt‐dependent signaling pathway in breast cancer cells: Role in cell proliferation

  2007cited by this paper
• Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1

  2006cited by this paper
• Regulation of the Expression of Caspase-9 by the Transcription Factor Activator Protein-4 in Glucocorticoid-induced Apoptosis*

  2005cited by this paper
• Functional analysis of a promoter variant of the gene encoding the interferon-gamma receptor chain I

  2003cited by this paper
• A decade of tyrosine kinases: from gene discovery to therapeutics.

  2003cited by this paper
• RFX1 and NF-1 associate with P sequences of the human growth hormone locus in pituitary chromatin.

  2003cited by this paper
• An inhibitory function for JNK in the regulation of IGF-I signaling in breast cancer

  2003influential reference
• The function of the protein tyrosine phosphatase SHP-1 in cancer.

  2003cited by this paper
• Mediation of Interleukin-1 (cid:1) –Induced Transforming Growth Factor (cid:1) 1 Expression by Activator Protein 4 Transcription Factor in Primary Cultures of Bovine Articular Chondrocytes Possible Cooperation With Activator Protein 1

  2003cited by this paper
• SHP-1 negatively regulates neuronal survival by functioning as a TrkA phosphatase

  2003cited by this paper
• The Role of the IGF System in Cancer: From Basic to Clinical Studies and Clinical Applications

  2002cited by this paper
• Transcriptional Regulation of Fcgr2b Gene by Polymorphic Promoter Region and Its Contribution to Humoral Immune Responses1

  2002influential reference
• The true face of JNK activation in apoptosis

  2002cited by this paper
• The IGF system and breast cancer.

  2001cited by this paper
• SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

  2001influential reference
• Recent advances in molecular genetics of breast cancer

  2001influential reference
• Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias : combination analysis with cDNA expression array and tissue microarray.

  2001cited by this paper
• Insulin-like growth factor I activates c-Jun N-terminal kinase in MCF-7 breast cancer cells.

  2000cited by this paper
• Tyrosine kinase signalling in breast cancer

  2000cited by this paper
• The Epstein-Barr Virus Promoter Initiating B-Cell Transformation Is Activated by RFX Proteins and the B-Cell-Specific Activator Protein BSAP/Pax5

  2000cited by this paper
• Methylation of Transcription Factor Binding Sites in the Epstein-Barr Virus Latent Cycle Promoter Wp Coincides with Promoter Down-Regulation during Virus-Induced B-Cell Transformation

  2000cited by this paper
• Dimeric RFX Proteins Contribute to the Activity and Lineage Specificity of the Interleukin-5 Receptor α Promoter through Activation and Repression Domains

  1999cited by this paper
• Involvement of RFX1 Protein in the Regulation of the Human Proliferating Cell Nuclear Antigen Promoter*

  1999cited by this paper
• Printed in U.S.A. Copyright © 1999 by The Endocrine Society Insulin-Like Growth Factor I Is Essential for Terminal End Bud Formation and Ductal Morphogenesis during

  1999cited by this paper
• The molecular biology of breast cancer: accelerating clinical applications.

  1998cited by this paper
• SHP-1 Binds and Negatively Modulates the c-Kit Receptor by Interaction with Tyrosine 569 in the c-Kit Juxtamembrane Domain

  1998cited by this paper
• The Tyrosine Phosphatase SHP-1 Associates with the sst2 Somatostatin Receptor and Is an Essential Component of sst2-mediated Inhibitory Growth Signaling*

  1997cited by this paper
• Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.

  1997cited by this paper
• The Tyrosine Phosphatase PTP1C Associates with Vav, Grb2, and mSos1 in Hematopoietic Cells (*)

  1996cited by this paper
• MLK‐3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6.

  1996cited by this paper
• Localization and down-regulating role of the protein tyrosine phosphatase PTP2C in membrane ruffles of PDGF-stimulated cells.

  1996cited by this paper
• Human protein tyrosine phosphatase 1C (PTPN6) gene structure: alternate promoter usage and exon skipping generate multiple transcripts.

  1995influential reference
• A synthetic inhibitor of the mitogen-activated protein kinase cascade.

  1995cited by this paper
• Involvement of SH2-containing Phosphotyrosine Phosphatase Syp in Erythropoietin Receptor Signal Transduction Pathways (*)

  1995cited by this paper
• Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling

  1995cited by this paper
• RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins

  1994cited by this paper
• Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice

  1993cited by this paper
• Transcription factor RFX1 helps control the promoter of the mouse ribosomal protein-encoding gene rpL30 by binding to its alpha element.

  1993cited by this paper
• NF-I proteins from brain interact with the proenkephalin cAMP inducible enhancer.

  1991cited by this paper
• Genomic Alterations in Human Breast Cancer: A Review

  1989cited by this paper
• Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer.

  1989cited by this paper
• Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro

  1988cited by this paper
• Evidence for an increased somatomedin-C/insulin-like growth factor I content in primary human lung tumors.

  1986cited by this paper
• Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas.

  1986cited by this paper

• No citing papers are available for this paper.